Skip to main content
OpenTrials
Completed

NCT Number: NCT02286050

Effect of a Nursing Program for Patients With Cystic Fibrosis on Disease Management

The purpose of this study is to evaluate the effect of a nursing program in patients with cystic fibrosis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cystic Fibrosis Congenital, Hereditary, and Neonatal Diseases and Abnormalities Digestive System Diseases Genetic Diseases, Inborn Infant, Newborn, Diseases Lung Diseases Pancreatic Diseases Respiratory Tract Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital Zurich

Zurich, 8091, Switzerland

About this study

All patients living with cystic fibrosis will be asked by questionnaire before (November 2014) and after (September 2016) the implementation of the program about their satisfaction with treatment, trust in the CF-Team, adherence, self-efficacy, treatment burden and quality of life.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Cystic Fibrosis

Exclusion criteria

  • None

Treatment and study plan

CF Nursing Program

Other

Primary outcomes

  1. Difference between baseline patient satisfaction and month 22

    Time frame: month 22

    Self-reported patient satisfaction will be measured with a newly developped questionnaire.

Secondary outcomes

  1. Difference between baseline adherence and month 22

    Time frame: month 22

    Self-reported adherence to therapy will be measured with the Medication Adherence Report Scale (MARS) and a newly developped questionnaire.

  2. Difference between baseline self-efficacy and month 22

    Time frame: month 22

    Self-reported self-efficacy to master the the therapeutic regimen will be measured with a newly developped questionnaire.

  3. Difference between baseline treatment burden and month 22

    Time frame: month 22

    Self-reported treatment burden will be measured wiht a subscale of the CFQ-R.

  4. Difference between baseline trust and month 22

    Time frame: month 22

    Self-reported trust will be measured with the short version of the Wake Forest Trust Scale.

  5. Difference between baseline information need and month 22

    Time frame: month 22

    Information needs will be assessed with a subscale of the PICKER-questionnaire for patients with CF.

Other outcomes

  1. Difference between baseline QoL and month 22

    Time frame: month 22

    Self-reported QoL will be measured with the Cystic Fibrosis Questionnaire - revised (CFQ-R) and the VAS of the European Quality of Life Instrument - 5 dimensions (EQ-5D VAS).

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Registry information

Official study title

Auswirkung Eines CF Nursing-Programms Auf Das Krankheitsmanagement Und Die Erfahrungen Der Behandlung Von Patientinnen Und Patienten

Important dates

Study start
2014
Primary completion
2017
Study completion
2017
First posted
Nov 7, 2014
Registry last updated
May 10, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.